Recent policy changes have boosted the role of advanced practice providers (APPs) in oncology clinical trials, but education is needed to enhance accrual and improve conduct of clinical trials, according…
Part 1 of a two-part series Fertility Preservation Provides Options for Patients With Cancer Fertility preservation is a meaningful and important part of survivorship for patients who are being treated…
Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP The Food and Drug Administration approved Carvykti (ciltacabtagene autocleucel, Janssen Biotech Inc.) in February 2022 making it the second chimeric antigen receptor (CAR) T-cell therapy…
Amanda Y. Tam, MS, FNP-BC The standard of care with curative intent for resectable or borderline resectable pancreatic adenocarcinoma involves surgery and then adjuvant chemotherapy. High-risk features include the following:…
Lucia Diaz, DNP, ANP-BC, CUNP It is estimated that between 19% and 100% of patients receiving antineoplastic medications known to cause neuropathy may develop chemotherapy-induced peripheral neuropathy (CIPN)1, which may…
Beth Sandy, MSN, CRNP When I was growing up, many kids that I associated with started smoking cigarettes around junior high school. I am happy to say that we have…
In this interview with The Oncology Connection, Colleen Tetzlaff, PA-C, president of the Association of Physician Assistants in Oncology (APAO), discusses the many reasons professional association membership is important for…
Taylor A. Aldridge, MMS, PA-C Pancreatic ductal adenocarcinoma (PDAC) is a notoriously aggressive gastrointestinal malignancy with an overall 5-year survival rate of 5%.1 This grim prognosis is primarily due to…